Detalhe da pesquisa
1.
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
N Engl J Med
; 390(4): 301-313, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38084760
2.
[How Myelodysplastic Syndrome is Diagnosed]. / Wie werden myelodysplastische Syndrome diagnostiziert?
Ther Umsch
; 79(2): 77-85, 2022.
Artigo
em Alemão
| MEDLINE | ID: mdl-35291852
4.
Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir.
BJU Int
; 121(4): 600-609, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29161753
5.
The novel ß2-selective proteasome inhibitor LU-102 synergizes with bortezomib and carfilzomib to overcome proteasome inhibitor resistance of myeloma cells.
Haematologica
; 100(10): 1350-60, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26069288
6.
The Absolute Monocyte Count at Diagnosis Affects Prognosis in Myelodysplastic Syndromes Independently of the IPSS-R Risk Score.
Cancers (Basel)
; 15(14)2023 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37509235
7.
Humoral and cellular BNT162b2 mRNA-based booster vaccine-induced immunity in patients with multiple myeloma and persistence of neutralising antibodies: results of a prospective single-centre cohort study.
Swiss Med Wkly
; 153: 40090, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410944
8.
CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study.
Cancers (Basel)
; 15(5)2023 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900271
9.
Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study.
Cancers (Basel)
; 15(19)2023 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37835392
11.
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial.
Blood Adv
; 5(4): 1110-1121, 2021 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33616652
12.
Guideline-based indicators for adult patients with myelodysplastic syndromes.
Blood Adv
; 4(16): 4029-4044, 2020 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32841339
13.
Aplastic anemia and concomitant autoimmune diseases.
Ann Hematol
; 88(7): 659-65, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19139895
14.
Posterior reversible encephalopathy syndrome during induction chemotherapy for acute myeloid leukaemia.
Eur J Haematol
; 92(1): 90, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23927542
15.
Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients.
Blood Cancer J
; 9(8): 63, 2019 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31399557
16.
Pyrazinamide-induced sideroblastic anemia.
Am J Hematol
; 87(3): 305, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21818765
17.
Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesis.
Cytometry B Clin Cytom
; 86(6): 397-409, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24677789
18.
Decreased generation of procoagulant platelets detected by flow cytometric analysis in patients with bleeding diathesis.
Cytometry B Clin Cytom
; 2014 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24458871
19.
The fibroblast: sentinel cell and local immune modulator in tumor tissue.
Int J Cancer
; 108(2): 173-80, 2004 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-14639599
20.
Tumor-associated fibroblasts recruit blood monocytes into tumor tissue.
Eur J Immunol
; 33(5): 1311-20, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12731056